Related references
Note: Only part of the references are listed.Bisphosphonates Induce Autophagy by Depleting Geranylgeranyl Diphosphate
Brian M. Wasko et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: An analysis of 65,396 hospitalizations from 344 hospitals participating in Get With The Guidelines (GWTG)
Usman Javed et al.
AMERICAN HEART JOURNAL (2010)
Synthesis and biological evaluation of a series of aromatic bisphosphonates
Rocky J. Barney et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Molecular mechanisms involved in farnesol-induced apoptosis
Joung Hyuck Joo et al.
CANCER LETTERS (2010)
Pleiotropic Effects of Statins - Basic Research and Clinical Perspectives
Qian Zhou et al.
CIRCULATION JOURNAL (2010)
Pharmacologic Inhibition of Squalene Synthase and Other Downstream Enzymes of the Cholesterol Synthesis Pathway A New Therapeutic Approach to Treatment of Hypercholesterolemia
Stephanie Seiki et al.
CARDIOLOGY IN REVIEW (2009)
Lipophilic Bisphosphonates as Dual Farnesyl/Geranylgeranyl Diphosphate Synthase Inhibitors: An X-ray and NMR Investigation
Yonghui Zhang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Adverse Effects of Statins - Mechanisms and Consequences
Jerzy Beltowski et al.
CURRENT DRUG SAFETY (2009)
Current and future pharmacologic options for the management of patients unable to achieve low-density lipoprotein-cholesterol goals with statins
Karim El Harchaoui et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2008)
Mono- and dialkyl isoprenoid bisphosphonates as geranylgeranyl diphosphate synthase inhibitors
Andrew J. Wiemer et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Pivaloyloxymethyl-modified isoprenoid bisphosphonates display enhanced inhibition of cellular geranylgeranylation
Andrew J. Wiemer et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Emerging lipid-lowering drugs: squalene synthase inhibitors
Raghda K. Elsayed et al.
EXPERT OPINION ON EMERGING DRUGS (2008)
Prodrugs of phosphates and phosphonates
Scott J. Hecker et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
The safety of statins in clinical practice
Jane Armitage
LANCET (2007)
Zoledronic acid-induced IPP/ApppI production in vivo
Hannu Monkkonen et al.
LIFE SCIENCES (2007)
Protective effects of a squalene synthase inhibitor, lapaquistat acetate (TAK-475), on statin-induced myotoxicity in guinea pigs
Tomoyaki Nishimoto et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2007)
Synthesis and biological activity of isoprenoid bisphosphonates
Larry W. Shull et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes - The treating to new targets (TNT) study
James Shepherd et al.
DIABETES CARE (2006)
Novel insights into actions of bisphosphonates on bone: Differences in interactions with hydroxyapatite
G. H. Nancollas et al.
BONE (2006)
A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates
H Mönkkönen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Copper-mediated displacements of allylic THP ethers on a bisphosphonate template
LW Shull et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2005)
Simultaneous determination of farnesyl and geranylgeranyl pyrophosphate levels in cultured cells
HX Tong et al.
ANALYTICAL BIOCHEMISTRY (2005)
Squalene synthase inhibitors suppress triglyceride biosynthesis through the farnesol pathway in rat hepatocytes
H Hiyoshi et al.
JOURNAL OF LIPID RESEARCH (2003)
Comparing myotoxic effects of squalene synthase inhibitor, T-91485, and 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in human myocytes
T Nishimoto et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Increased nitric oxide bioavailability in endothelial cells contributes to the pleiotropic effect of cerivastatin
L Kalinowski et al.
CIRCULATION (2002)
Squalene synthase inhibitors reduce plasma triglyceride through a low-density lipoprotein receptor-independent mechanism
H Hiyoshi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Crystal structure of human squalene synthase - A key enzyme in cholesterol biosynthesis
J Pandit et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
